{"version":"1.0","provider_name":"NRAS","provider_url":"https://nras.org.uk/de/","author_name":"Sadé","author_url":"https://nras.org.uk/de/author/sade/","title":"Sequenzielle Anwendung fortgeschrittener Therapien | NRAS","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"GmDJYX045T\"><a href=\"https://nras.org.uk/de/resource/three-strikes-and-you-are-out/\">Sequenzielle Anwendung fortgeschrittener Therapien</a></blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https://nras.org.uk/de/resource/three-strikes-and-you-are-out/embed/#?secret=GmDJYX045T\" width=\"600\" height=\"338\" title=\"&#x201E;Sequenzielle Anwendung fortgeschrittener Therapien&#x201C; &#x2013; NRAS\" data-secret=\"GmDJYX045T\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"></iframe><script>\n/*! This file is auto-generated */\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n//# sourceURL=https://nras.org.uk/wp-includes/js/wp-embed.min.js\n</script>\n","thumbnail_width":696,"thumbnail_height":696,"description":"Seit einiger Zeit befürchtet NRAS, dass einige Integrated Care Boards (ICBs) in England den Zugang zu fortschrittlichen Therapien (Biologika, Biosimilars/JAK-Inhibitoren) künstlich einschränken. Daher stellten wir 2019 einen Antrag auf Informationsfreiheit an alle Clinical Commissioning Groups (CCGs) (wie sie damals hießen). Unsere Patientenbeauftragte, Ailsa Bosworth, hat sich seitdem dafür eingesetzt, dass die Angelegenheit geklärt wird. […]"}